the trial is designed to only take in the sickest patients, thus efficacy is almost guaranteed at 300 enrolled. this is why recruitment is so slow because these patients are very hard to find and are the minority of the sick people out there. 45 or 60% enrolment trial stoppage would be a bonus but this is designed to ensure success for the future treatment of all ARDS not just Covid. SI and team are forward thinkers and brilliant.
the trial is designed to only take in the sickest patients, thus...
-
- There are more pages in this discussion • 7,440 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
98.5¢ |
Change
-0.010(1.01%) |
Mkt cap ! $1.124B | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.01 | 98.0¢ | $396.6K | 400.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 28557 | 98.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.0¢ | 57083 | 30 |
View Market Depth
| Last trade - 10.47am 20/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |